Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity.
| Autor: | Scaltriti, M.1, Verma, C.2, Guzman, M.1, Jimenez, J.3, Parra, J. L.1, Pedersen, K.1, Smith, D. J.2, Landolfi, S.3, Ramon y Cajal, S.3, Arribas, J.1, Baselga, J.1,4 jbaselga@vhebron.net |
|---|---|
| Zdroj: | Oncogene. 2/12/2009, Vol. 28 Issue 6, p803-814. 12p. 1 Diagram, 1 Chart, 5 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|